Providing real-time information that enables correct energy lesion and delivery control.

Take action initiates enrollment in TEMPASURE cardiac ablation catheter CE Tag clinical trial Advanced Cardiac Therapeutics, Inc. The TEMPASURE system is the world’s initial RF cardiac ablation catheter to offer both saline irrigation and temperature-sensing technology http://www.tadaciped.com . The system’s novel passive sensing microwave radiometry technology allows the electrophysiologist to measure the heat of cardiac cells at three millimeters depth through the ablation procedure, providing real-time information that enables correct energy lesion and delivery control. ‘ACT’s novel catheter program directly measures lesion creation through temperatures, addressing a longstanding issue for physicians performing irrigated cardiac ablation,’ stated Karl-Heinz Kuck, M.D., mind of the Section of Cardiology, St Georg Medical center, Germany, who is co-principal investigator of the trial.

‘Stargardt’s disease is currently untreatable, and is among the leading causes of juvenile blindness in the global world. Collectively, degenerative eye illnesses afflict over 25 million people in the U.S. And Europe alone. These illnesses have a devastating impact on patients and their families, which has been a strong motivating factor for developing this new treatment. In Stargardt’s disease, the increased loss of RPE cells in the patient’s macula causes a loss of photoreceptors – the cones and rods with which we see – resulting in blindness.